Summary Mutations at the hMSH2 and hMLHI mismatch repair loci have been implicated in the pathogenesis of colorectal cancer. Tumours with two allelic mutations at a mismatch repair locus develop replication errors (RERs). In the hereditary non-polyposis colorectal cancer (HNPCC) syndrome, one mutation is inherited and the other acquired somatically; in RER+ sporadic colorectal cancers, both mutations are somatic. RER+ tumours tend to have a low frequency of allele loss, presumably because they acquire most mutations through RERs. However, before a second mismatch repair mutation has occurred somatically, there is no reason to suppose that allele loss occurs less frequently in tumours that are to become RER+. Indeed, this second mutation might itself occur by allele loss. We have searched for allele loss at the hMSH2 and hMLHI loci in RER+ and RER-sporadic colorectal cancers. Loss occurred at the hMLHl locus in 7/17 (41%) RER+ tumours, compared with 6/40 (15%) RER-cancers (X2=3.82, P-0.05). At hMSH2, 2/22 RER+ sporadic cancers (9%) had lost an allele, compared with 2/40 (5%) RER-cancers (X2=0.03, P>0.5).
Germ-line mutations at the DNA mismatch repair loci hMSH2, hMLHI, hPMSI and hPMS2 cause the hereditary non-polyposis colorectal cancer (HNPCC) syndrome (Peltomaki, 1995) . Patients develop carcinomas of the colon, stomach, ovary, uterus and other specific sites (Jass et al., 1994) . The cancers of HNPCC patients show replication errors (RERs), a manifestation of which is instability at microsatellite loci (Fishel and Kolodner, 1995) . Some sporadic cases of colorectal cancer (CRC) also have microsatellite instability, presumably because of somatically acquired defects in mismatch repair (Aaltonen et al., 1993) . Mutations of mismatch repair genes have been found in sporadic colorectal cancers (Liu et al., 1995) .
It has been suggested that RERs comprise an alternative to allele loss [loss of heterozygosity (LOH), allelic imbalance] in the genetic pathways of colorectal tumorigenesis (Aaltonen et al., 1993) . Hence, whereas RER-tumours acquire many mutations by LOH, RER+ tumours tend to acquire mutations through errors of replication. This divergence between genetic pathways can only occur, however, after the cell becomes deficient in mismatch repair. If this deficiency is recessive, as seems probable (Radman and Wagner, 1993) , two allelic mutations must first occur at the hMSH2, hMLHI, hPMSI or hPMS2 loci (or some related locus). It follows that in RER+ tumours, LOH may occur relatively frequently at mismatch repair loci, thereby inactivating one mismatch repair allele, in a way similar to allele loss at tumour-suppressor loci.
This study determines whether or not allele loss at the hMSH2 and hMLHI mismatch repair loci is important in the pathogenesis of RER+ sporadic colorectal cancers. We have characterised a set of sporadic colorectal cancers as RER+ and RER-. Allele loss at hMSH2 and hMLHI (the mismatch repair loci most commonly involved in colorectal tumorigenesis) has been analysed in these cases. A set of colorectal cancer cell lines has also been analysed with respect to RER status and studied for LOH at hMSH2 and hMLHJ. (Gyapay et al., 1994) to study LOH at hMSH2 (D2S123, D2S391, D2S288 and D2SI19) and at hMLHI (D3S1611, D3S1612, D3S1277 and D3S1561) (Figure 1 ). PCR reactions were carried out as for D6S434 above and products were detected using the same method as was used for study of LOH in the sporadic CRCs. As above, any cases of microsatellite instability at the eight loci used to assess LOH were excluded from the analysis and the tumour deemed non-informative at that microsatellite locus.
Clinical data
From the sporadic cases, the following data were obtained: patient age at presentation; Dukes' tumour stage; Jass group; tumour grade (degree of differentiation); mucinous differentiation; and tumour site in the colon(left-or rightsided).
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RER analysis
The set of 24 RER+ and 48 RER-sporadic CRC cases was determined as described above. A negative association had been found between the frequency of LOH and RER+ status in these tumours (Tomlinson and Bodmer, 1996) . In the CRG cell lines, microsatellite instability was confirmed in those eight lines already reported as being RER+. All other CRC lines were found to be RER- (Table I ).
LOH at hMSH2 and hMLH1 in sporadic CRCs In the sporadic CRCs, LOH occurred at the hMLHI locus (Figure 2 ) in 7/17 (41%) RER+ tumours and in 6/40 (15%) RER-CRCs (Table II) . This difference is of borderline significance at the 5% level (Table II) . At hMSH2, a much lower frequency of LOH was found (Figure 2 Associations between clinical data and LOH in sporadic CRCs There was no significant difference between the clinicopathological features of the RER+ and RER-tumours studied here (details of statistical analyses not shown). There were trends in the data towards the RER+ tumours having a higher Dukes' stage and to being right-sided, in agreement with other authors. By chance, however, there was a predominance of left-sided colon cancers in our sample (63/ 72, 87.5%) and this probably prevented a significant association from being found between RER+ status and right-sided tumours. We found no association between RER status and patient age, the degree of tumour differentiation or Jass score. Too few tumours showed mucinous differentiation for a meaningful comparison to be made between the RER+ and RER-groups.
Further analysis showed no association between LOH at hMLHI or hMSH2 and any of the clinical data (age, stage, grade or site). This was true when all of the 72 sporadic CRCs were included in the analysis, or when only the 24 RER+ CRCs were included.
LOH at hMSH2 and hMLHI in CRC cell lines No cell line showed apparent homozygosity at all four microsatellite loci analysed, whether close to hMSH2 or hMLHJ. Indeed, every line was heterozygous at two or more of the four microsatellite marker loci used to study hMSH2 or hMLHJ.
Discussion
We have detected a relatively high frequency of LOH (41%) at hMLHI in sporadic RER+ colorectal cancers (that is, tumours with microsatellite instability). This frequency may slightly understate the true frequency of LOH, because tumours were not microdissected from normal tissue. A lower frequency of LOH (16%) occurred in RER-sporadic CRCs. This frequency may reflect random events or truly RER+ cancers in which microsatellite instability has not been detected. At hMSH2, allele loss was uncommon in both RER+ and RER-sporadic CRCs.
In 30 CRC cell lines studied, microsatellite instability was confirmed in eight cases and not detected in the other 22 lines. We found no cell line that had lost an allele at hMLHI or hMSH2 according to the criteria used in this study (see above), although small regions of loss cannot be excluded at hMSH2 in particular, because some of the markers used on chromosome 2 were several cM apart (Figure 1 ). Some CRC lines were apparently homozygous at the D2S391 and D3S1611 loci, which are the closest markers known to hMSH2 and hMLHI respectively, and it is possible that these tumours had lost alleles. This fact, and the small number of RER+ CRC cell lines identified, explain why the frequency of LOH at hMLHI is apparently lower in the cell lines than in the sporadic CRCs. The frequencies of LOH at hMSH2 and hMLHI reported here are in agreement with the results of Hemminki et al. (1994) . This previous study found a frequency of allele loss of 56% at D3S1611 in a sample of nine informative cancers from HNPCC patients and sporadic RER+ cancers. Combined, the data suggest that, at hMLHI, mismatch repair is dominant at the cellular level (that is, repair is normal before a second 'hit' occurs). The frequency of allele loss at hMLHI in the RER+ cancers (41%) is similar to that found at many putative tumour-suppressor loci in CRCs (Devilee et al., 1991) .
Given the results at hMLHI and the apparently similar effects of mutations at hMLHI and hMSH2, it is difficult to explain the low frequency of allele loss at hMSH2 that was found in this study and had also been found by Aaltonen et al. (1993) . One explanation is that LOH at hMSH2 and hMLHI affects unusually small regions of the chromosome: the markers used at hMLHJ lie within or close to the gene, whereas the markers used for hMSH2 are up to 2cM away, perhaps too far to detect some cases of LOH at hMSH2. There are, however, other explanations for the difference between allele loss at hMSH2 and hMLHI. The relative frequencies of hMLHI and hMSH2 mutations in sporadic CRCs are not fully known and it is possible that hMLHI mutations are more common, the low frequency of LOH at hMSH2 merely reflecting this fact (despite the finding that germ-line hMSH2 mutations are actually more frequent than hMLHI mutations in HNPCC). Alternatively, we can speculate that LOH at hMSH2 is disadvantageous, presumably because of effects on the dosage of contiguous genes with important cellular functions; the same reasoning may not apply to hMLHJ. A further possibility is that hMSH2 mutations are at least partially dominant and that some defect in mismatch repair in the 1.hMSH2/ + hMSH2 heterozygote biases the second 'hit' towards mismatch repair mutations away from LOH. Finally, we cannot discount the possibility that LOH at hMLHI is not directly related to mismatch repair, but primarily targets a nearby gene such as fl-catenin.
We conclude that allele loss at hMLHI probably contributes to the RER+ status of a significant proportion of sporadic colorectal cancers. Loss of heterozygosity at hMSH2 appears to be rare. Allele loss at both these mismatch repair loci occurs less frequently in RER-CRCs.
